The CDMO service mainly includes the following aspects:
Development and production of stem cells and immune cells (including CAR-T cells)
Detectionstem cells, immune cells (including CAR-T cells)
Biological potency, pharmacology and independent analysis
Process flow, transportation and storage, quality control and cooperative research
Rapid Approval Advisory Service for cell drugs
Cell technology transfer services
Molecular pathology, single-cell analysis, and tumor cell analysis